Purdue Settles Suit Over Off-Label Marketing of OxyContin

Drug Industry Daily
A A
Purdue Pharma has agreed to pay $19.5 million to settle a lawsuit filed by 26 states and the District of Columbia over off-label marketing of its narcotic pain medication OxyContin.

To View This Article:

Login

Subscribe To Drug Industry Daily